Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
作者信息
Abe T, Kazama M
出版信息
Thromb Diath Haemorrh. 1975 Nov 15;34(2):584.
PMID:53895
Abstract
摘要
相似文献
1
Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.会议论文：纤溶酶抑制剂对区分纤维蛋白原溶解和纤维蛋白溶解过程中消化作用的影响
Thromb Diath Haemorrh. 1975 Nov 15;34(2):584.
2
The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.血浆抑制剂对链激酶或尿激酶激活的纤溶酶的抑制作用。
Nihon Seirigaku Zasshi. 1977;39(5):112-4.
3
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.α2-纤溶酶抑制剂在纤溶状态下的行为。
J Clin Invest. 1977 Aug;60(2):361-9. doi: 10.1172/JCI108784.
4
Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma.论文集：正常血浆和纤溶血浆的纤维蛋白原降解
Thromb Diath Haemorrh. 1975 Nov 15;34(2):584.
5
Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Thromb Diath Haemorrh. 1975 Sep 30;34(1):351.
6
Alpha 2-plasmin inhibitor deficiency.
Lancet. 1979 Feb 10;1(8111):329. doi: 10.1016/s0140-6736(79)90744-x.
7
Serum inhibitors in fibrinolysis.纤维蛋白溶解中的血清抑制剂。
Br J Haematol. 1975 Oct;31(2):217-31. doi: 10.1111/j.1365-2141.1975.tb00852.x.
8
Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.纤溶酶原激活剂对α2-巨球蛋白与纤溶酶相互作用影响的研究。
Thromb Haemost. 1978 Oct 31;40(2):377-86.
9
[Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].[纤维蛋白溶解的分子机制及溶栓治疗的前景]
Vopr Med Khim. 1984 Sep-Oct;30(5):13-22.
10
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.健康与疾病中的纤维蛋白溶解：系统性红斑狼疮中的严重异常
J Lab Clin Med. 1984 Dec;104(6):962-76.
Zotero 插件